Indivior Pharmaceuticals, Inc.

Over the past 90 days, Indivior Pharmaceuticals (INDV) has reported zero cyber incidents and zero red-flag 8-K filings related to bankruptcy, delisting, restatement, or officer departures. However, a clean near-term filing record does not eliminate structural risks—dilution exposure, historical financing patterns, and forward-looking capital needs require deeper analysis. The full $49 Report extends the lookback to 12 months of 8-K context, maps the company's financing history and dilution trajectory, and applies AI-driven risk signals to quantify vulnerability to future capital raises and market stress. The full $49 Report adds those dimensions and delivers a consolidated risk score.